These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32588490)

  • 1. Immunoengineering has arrived.
    Green JJ
    J Biomed Mater Res A; 2021 Apr; 109(4):397-403. PubMed ID: 32588490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering vaccines and niches for immune modulation.
    Purwada A; Roy K; Singh A
    Acta Biomater; 2014 Apr; 10(4):1728-40. PubMed ID: 24373907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoengineering the next generation of arthritis therapies.
    Klimak M; Nims RJ; Pferdehirt L; Collins KH; Harasymowicz NS; Oswald SJ; Setton LA; Guilak F
    Acta Biomater; 2021 Oct; 133():74-86. PubMed ID: 33823324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing Immunomodulatory Polymers for Treatment of Autoimmunity, Allergy, and Transplant Rejection.
    Tu AB; Krishna G; Smith KR; Lewis JS
    Annu Rev Biomed Eng; 2024 Jul; 26(1):415-440. PubMed ID: 38959388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoengineering with biomaterials for enhanced cancer immunotherapy.
    Xie YQ; Wei L; Tang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1506. PubMed ID: 29333729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Materials engineering for immunomodulation.
    Hubbell JA; Thomas SN; Swartz MA
    Nature; 2009 Nov; 462(7272):449-60. PubMed ID: 19940915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of immunoengineering for systemic autoimmunity.
    McBride DA; Jones RM; Bottini N; Shah NJ
    Nat Rev Rheumatol; 2024 Apr; 20(4):203-215. PubMed ID: 38383732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic synthetic and natural materials for immunoengineering.
    Slezak A; Chang K; Hossainy S; Mansurov A; Rowan SJ; Hubbell JA; Guler MO
    Chem Soc Rev; 2024 Feb; 53(4):1789-1822. PubMed ID: 38170619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomaterial Strategies for Immunomodulation.
    Hotaling NA; Tang L; Irvine DJ; Babensee JE
    Annu Rev Biomed Eng; 2015; 17():317-49. PubMed ID: 26421896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical Immunoengineering of T cells for Therapeutic Applications.
    Lei K; Kurum A; Tang L
    Acc Chem Res; 2020 Dec; 53(12):2777-2790. PubMed ID: 33258577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering approaches to immunotherapy.
    Swartz MA; Hirosue S; Hubbell JA
    Sci Transl Med; 2012 Aug; 4(148):148rv9. PubMed ID: 22914624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological principles regulating immunomodulation with biomaterials.
    Khan TA; Reddy ST
    Acta Biomater; 2014 Apr; 10(4):1720-7. PubMed ID: 24342045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Freeze-drying for the preservation of immunoengineering products.
    Kommineni N; Butreddy A; Sainaga Jyothi VGS; Angsantikul P
    iScience; 2022 Oct; 25(10):105127. PubMed ID: 36267916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-Based Biomaterials for Immunoengineering.
    Maeda M; Kojima T; Song Y; Takayama S
    Adv Healthc Mater; 2019 Feb; 8(4):e1801243. PubMed ID: 30516349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging strategies to bypass transplant rejection via biomaterial-assisted immunoengineering: Insights from islets and beyond.
    Abbaszadeh S; Nosrati-Siahmazgi V; Musaie K; Rezaei S; Qahremani M; Xiao B; Santos HA; Shahbazi MA
    Adv Drug Deliv Rev; 2023 Sep; 200():115050. PubMed ID: 37549847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering Immune Tolerance with Biomaterials.
    Gammon JM; Jewell CM
    Adv Healthc Mater; 2019 Feb; 8(4):e1801419. PubMed ID: 30605264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoengineering strategies to enhance vascularization and tissue regeneration.
    Zarubova J; Hasani-Sadrabadi MM; Ardehali R; Li S
    Adv Drug Deliv Rev; 2022 May; 184():114233. PubMed ID: 35304171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic Cells as Targets for Biomaterial-Based Immunomodulation.
    Eslami-Kaliji F; Sarafbidabad M; Rajadas J; Mohammadi MR
    ACS Biomater Sci Eng; 2020 May; 6(5):2726-2739. PubMed ID: 33463292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnologies for Physiology-Informed Drug Delivery to the Lymphatic System.
    Maisel K; McClain CA; Bogseth A; Thomas SN
    Annu Rev Biomed Eng; 2023 Jun; 25():233-256. PubMed ID: 37000965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell immunoengineering with advanced biomaterials.
    Delcassian D; Sattler S; Dunlop IE
    Integr Biol (Camb); 2017 Mar; 9(3):211-222. PubMed ID: 28252135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.